Core Scientific (CORZ) Competitors

Core Scientific (NASDAQ:CORZ) and Banco Santander-Chile (NYSE:BSAC) are both finance companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, community ranking, profitability, institutional ownership, analyst recommendations, earnings and valuation.

Does the media prefer CORZ or BSAC?

In the previous week, Core Scientific had 7 more articles in the media than Banco Santander-Chile. MarketBeat recorded 8 mentions for Core Scientific and 1 mentions for Banco Santander-Chile. Core Scientific's average media sentiment score of 1.16 beat Banco Santander-Chile's score of 0.20 indicating that Core Scientific is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Core Scientific	3 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Banco Santander-Chile	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Is CORZ or BSAC more profitable?

Banco Santander-Chile has a net margin of 19.16% compared to Core Scientific's net margin of 0.00%. Banco Santander-Chile's return on equity of 19.15% beat Core Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Core Scientific	N/A	N/A	N/A
Banco Santander-Chile	19.16%	19.15%	1.18%

Which has more volatility & risk, CORZ or BSAC?

Core Scientific has a beta of 6.3, indicating that its stock price is 530% more volatile than the S&P 500. Comparatively, Banco Santander-Chile has a beta of 0.68, indicating that its stock price is 32% less volatile than the S&P 500.

Do analysts rate CORZ or BSAC?

Core Scientific presently has a consensus target price of $18.44, indicating a potential upside of 55.13%. Banco Santander-Chile has a consensus target price of $23.00, indicating a potential downside of 7.13%. Given Core Scientific's stronger consensus rating and higher possible upside, research analysts plainly believe Core Scientific is more favorable than Banco Santander-Chile.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Core Scientific	0 Sell rating(s)	0 Hold rating(s)	18 Buy rating(s)	2 Strong Buy rating(s)	3.10
Banco Santander-Chile	1 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.75

Does the MarketBeat Community prefer CORZ or BSAC?

Banco Santander-Chile received 195 more outperform votes than Core Scientific when rated by MarketBeat users. However, 75.00% of users gave Core Scientific an outperform vote while only 53.75% of users gave Banco Santander-Chile an outperform vote.

Company	Underperform	Outperform
Core Scientific	Outperform Votes 63 75.00%	Underperform Votes 21 25.00%
Banco Santander-Chile	Outperform Votes 258 53.75%	Underperform Votes 222 46.25%

Do institutionals & insiders have more ownership in CORZ or BSAC?

6.4% of Banco Santander-Chile shares are held by institutional investors. 1.4% of Core Scientific shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Which has higher earnings and valuation, CORZ or BSAC?

Banco Santander-Chile has higher revenue and earnings than Core Scientific. Core Scientific is trading at a lower price-to-earnings ratio than Banco Santander-Chile, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Core Scientific	$410.91M	8.62	-$1.50B	-$5.03	-2.36
Banco Santander-Chile	$2.74T	0.00	$883.95M	$2.29	10.81

Summary

Core Scientific beats Banco Santander-Chile on 10 of the 19 factors compared between the two stocks.